FOXM1 and breast cancer: These compounds suppress the activity of the cell cycle regulator FOXM1, which is overexpressed in many breast cancers, and in a variety of other cancers, including ovarian, pancreatic, lung, colon, and glioblastoma [3,5,6,10,11,20,21].